These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 15657384)

  • 21. Decreases in phosphoinositide-3-kinase/Akt and extracellular signal-regulated kinase 1/2 signaling activate components of spinal motoneuron death.
    Newbern J; Taylor A; Robinson M; Li L; Milligan CE
    J Neurochem; 2005 Sep; 94(6):1652-65. PubMed ID: 16045454
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Attenuation of myocardial ischemia-reperfusion injury by trimetazidine derivatives functionalized with antioxidant properties.
    Kutala VK; Khan M; Mandal R; Ganesan LP; Tridandapani S; Kalai T; Hideg K; Kuppusamy P
    J Pharmacol Exp Ther; 2006 Jun; 317(3):921-8. PubMed ID: 16467453
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Indomethacin induces apoptosis in 786-O renal cell carcinoma cells by activating mitogen-activated protein kinases and AKT.
    Ou YC; Yang CR; Cheng CL; Raung SL; Hung YY; Chen CJ
    Eur J Pharmacol; 2007 Jun; 563(1-3):49-60. PubMed ID: 17341418
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Letter regarding article by Argaud et al, "postconditioning inhibits mitochondrial permeability transition".
    Facundo HT; Kowaltowski AJ
    Circulation; 2005 Jun; 111(24):e442; author reply e442. PubMed ID: 15967857
    [No Abstract]   [Full Text] [Related]  

  • 25. Role of hydrogen sulfide in the cardioprotection caused by ischemic preconditioning in the rat heart and cardiac myocytes.
    Bian JS; Yong QC; Pan TT; Feng ZN; Ali MY; Zhou S; Moore PK
    J Pharmacol Exp Ther; 2006 Feb; 316(2):670-8. PubMed ID: 16204473
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Protein phosphatase 2A-negative regulation of the protective signaling pathway of Ca2+/CaM-dependent ERK activation in cerebral ischemia.
    Zhao J; Wu HW; Chen YJ; Tian HP; Li LX; Han X; Guo J
    J Neurosci Res; 2008 Sep; 86(12):2733-45. PubMed ID: 18478546
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Through the looking glass: a positive inotropic drug and ischemic preconditioning.
    Vander Heide RS; Marsh JD
    Circulation; 1997 Apr; 95(8):1989-91. PubMed ID: 9133503
    [No Abstract]   [Full Text] [Related]  

  • 28. Akt1 in the cardiovascular system: friend or foe?
    O'Neill BT; Abel ED
    J Clin Invest; 2005 Aug; 115(8):2059-64. PubMed ID: 16075047
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Molecular mechanisms of myocardial anti-ischemic protection by pharmacologic agents (a review of the literature)].
    Seĭfulla RD; Onishchenko NA; Krasova EI; Timofeev AB
    Farmakol Toksikol; 1980; 43(4):433-9. PubMed ID: 6160054
    [No Abstract]   [Full Text] [Related]  

  • 30. Targeting mitochondrial calcium transport in myocardial infarction.
    Frangogiannis NG
    Hellenic J Cardiol; 2018; 59(4):223-225. PubMed ID: 29940221
    [No Abstract]   [Full Text] [Related]  

  • 31. Thymosin beta4 is cardioprotective after myocardial infarction.
    Srivastava D; Saxena A; Michael Dimaio J; Bock-Marquette I
    Ann N Y Acad Sci; 2007 Sep; 1112():161-70. PubMed ID: 17600280
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Neutralizing MAP4K4.
    Nicholls M
    Eur Heart J; 2019 Jun; 40(22):1752-1753. PubMed ID: 31173092
    [No Abstract]   [Full Text] [Related]  

  • 33. Turning necrosis into apoptosis: the exacting task that can enhance survival.
    Chen-Scarabelli C; Scarabelli TM
    Am Heart J; 2004 Aug; 148(2):196-9. PubMed ID: 15308988
    [No Abstract]   [Full Text] [Related]  

  • 34. Obesity induces signs of premature cardiac aging in younger patients: the role of mitochondria.
    Niemann B; Chen Y; Teschner M; Li L; Silber RE; Rohrbach S
    J Am Coll Cardiol; 2011 Feb; 57(5):577-85. PubMed ID: 21272749
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [The effects of TA-064, dopamine and isoproterenol on the acutely ischemic myocardium].
    Tokutake E; Watanabe I; Saito T; Hibiya K; Takahasi N; Ogura T; Yumikura S; Nagasawa M; Saito S; Ozawa Y
    Kokyu To Junkan; 1985 Jul; 33(7):897-902. PubMed ID: 4059680
    [No Abstract]   [Full Text] [Related]  

  • 36. The pharmacological protection of mitochondrial function in hypoxic heart [proceedings].
    Nayler WG
    Br J Pharmacol; 1978 Mar; 62(3):449P. PubMed ID: 638367
    [No Abstract]   [Full Text] [Related]  

  • 37. Extracellular signalling molecules in the ischaemic/reperfused heart - druggable and translatable for cardioprotection?
    Kleinbongard P; Heusch G
    Br J Pharmacol; 2015 Apr; 172(8):2010-25. PubMed ID: 25204973
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Stromal derived factor 1α: a chemokine that delivers a two-pronged defence of the myocardium.
    Bromage DI; Davidson SM; Yellon DM
    Pharmacol Ther; 2014 Sep; 143(3):305-15. PubMed ID: 24704323
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ischemia/reperfusion injury and cardioprotective mechanisms: Role of mitochondria and reactive oxygen species.
    Perrelli MG; Pagliaro P; Penna C
    World J Cardiol; 2011 Jun; 3(6):186-200. PubMed ID: 21772945
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Long-term follow-up of patients undergoing postconditioning during ST-elevation myocardial infarction.
    Garcia S; Henry TD; Wang YL; Chavez IJ; Pedersen WR; Lesser JR; Shroff GR; Moore L; Traverse JH
    J Cardiovasc Transl Res; 2011 Feb; 4(1):92-8. PubMed ID: 21136310
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.